HANXBIO-B (03378) spent 98.85 million Hong Kong dollars to repurchase 31,200 shares on April 22nd.
Hansea Investment Limited (03378) issued an announcement that on April 22, 2026, the company spent 0.985 million Hong Kong dollars to repurchase 31,200 shares at a repurchase price of 31.18-31.98 Hong Kong dollars per share.
HANXBIO-B(03378) announced on April 22, 2026 that the company spent HK$0.985 million to repurchase 31,200 shares at a repurchase price of HK$31.18-31.98 per share.
Related Articles
AGILE GROUP (03383) subsidiary intends to sell 50% equity interest in Zhejiang Xiangya Real Estate Development for about RMB 95 million.
DL Holdings GP (01709) spent HK$620,700 to repurchase 600,000 shares on April 22.
CSTONE PHARMA-B (02616) issued 118 million new shares in accordance with the placing agreement.
AGILE GROUP (03383) subsidiary intends to sell 50% equity interest in Zhejiang Xiangya Real Estate Development for about RMB 95 million.
DL Holdings GP (01709) spent HK$620,700 to repurchase 600,000 shares on April 22.
CSTONE PHARMA-B (02616) issued 118 million new shares in accordance with the placing agreement.
RECOMMEND
DeepSeek’s $10 Billion Valuation Financing Rumor And Four Layers Of Logical Judgment
21/04/2026
48 Hours Witness AI’s New Battlefield: Alibaba Joins, Tencent Open Sources, Manycore Tech Lists — Has The World Model Reached Its ChatGPT Moment?
21/04/2026
Public Fund Giants Reverse Course With Heavy Hong Kong IPO Cornerstone Allocations Exceeding HK$2.2 Billion Year‑To‑Date
21/04/2026
